4-(4-chlorophenyl)-4-hydroxypiperidine has been researched along with 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belpaire, FM; De Vriendt, C; Pan, LP | 1 |
Arinobu, T; Hattori, H; Ishii, A; Seno, H; Suzuki, O | 1 |
2 other study(ies) available for 4-(4-chlorophenyl)-4-hydroxypiperidine and 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol
Article | Year |
---|---|
In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.
Topics: Adolescent; Adult; Aged; Child; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Haloperidol; Humans; Isoenzymes; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Oxidation-Reduction; Piperidines | 1998 |
Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolites.
Topics: Antipsychotic Agents; Biotransformation; Chromatography, High Pressure Liquid; Haloperidol; Humans; Mass Spectrometry; Pharmaceutical Preparations; Piperidines; Ultrasonics | 2002 |